Sunny Pharmtech Inc.
6676
Rank in Stocks
#23742
Based in Taoyuan, Taiwan, and established in 1994, Sunny Pharmtech Inc. focuses... Based in Taoyuan, Taiwan, and established in 1994, Sunny Pharmtech Inc. focuses on the entire lifecycle of pharmaceutical products, from initial research and development to manufacturing and global sales. Its operations encompass both active pharmaceutical ingredients (APIs) and finished medicinal products. The company's extensive product range includes: A lidocaine ointment, which functions as an anesthetic lubricant for intubation procedures and offers temporary relief from discomfort associated with minor burns, sunburn, skin abrasions, and insect stings. Cyanocobalamin injections, prescribed to treat vitamin B12 deficiency and pernicious anemia caused by malabsorption issues. Nitrofurantoin capsules, used in the treatment of urinary tract infections. Aminocaproic acid tablets, indicated for managing certain blood disorders and conditions involving excessive proteolytic enzyme activity. Carboprost tromethamine injections, utilized in therapeutic abortions and to address postpartum hemorrhage.
Share Price
$0.2310722
Last synced: 2026-11-10
Market Cap
$39.21M
Change (1 day)
-5.60%
Change (1 year)
-47.96%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Sunny Pharmtech Inc. (6676)
Category
Healthcare
EPS for Sunny Pharmtech Inc. (6676)
EPS as of June 2026 TTM: $-0.07
According to Sunny Pharmtech Inc.'s latest financial reports, its current EPS (TTM) is $-0.07. At the end of 2025 the company had an EPS of $-0.06, a decrease compared to its 2024 EPS of $-0.03.
EPS history for Sunny Pharmtech Inc. from 2014 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.07 | 10.17% |
| 2025 | $-0.06 | 102.19% |
| 2024 | $-0.03 | 123.78% |
| 2023 | $-0.01 | -64.34% |
| 2022 | $-0.04 | -13.20% |
| 2021 | $-0.05 | 68.61% |
| 2020 | $-0.03 | -53.40% |
| 2019 | $-0.06 | -32.88% |
| 2018 | $-0.09 | 1.51% |
| 2017 | $-0.09 | 3.73% |
| 2016 | $-0.08 | -37.63% |
| 2015 | $-0.13 | 80.03% |
| 2014 | $-0.07 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -23,791.38% |
US
|
|
| $-7.07 | 10,595.92% |
US
|
|
| $-5.29 | 7,903.03% |
AU
|
|
| $12.88 | -19,585.78% |
BE
|
|
| $21.56 | -32,717.25% |
NL
|
Questions about Sunny Pharmtech Inc.'s earnings per share (EPS)
What is Sunny Pharmtech Inc.'s earnings per share (EPS)?
Sunny Pharmtech Inc.'s earnings per share (EPS) over the last twelve months is $-0.07, as of Jun 2026.
What was Sunny Pharmtech Inc.'s earnings per share (EPS) in 2025?
In 2025, Sunny Pharmtech Inc.'s earnings per share (EPS) was $-0.06, compared with $-0.03 in 2024.
How has Sunny Pharmtech Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Sunny Pharmtech Inc.'s earnings per share (EPS) was highest in 2023 ($-0.01) and lowest in 2025 ($-0.06).
How does Sunny Pharmtech Inc.'s earnings per share (EPS) compare with similar companies?
Sunny Pharmtech Inc.'s earnings per share (EPS) ($-0.07) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.